CanSORT investigates a wide array of cancer groups including breast, thyroid, colorectal, and prostate cancer primarily through survey methods, medical record assessment, and claims data reviews. Frequently, CanSORT research involves working with patients, as well as their providers to learn about decision making processes, comparative effectiveness of various treatments and the effects of a wide variety of patient and clinician factors on immediate cancer outcomes and long-term survivorship issues such as quality of life, economical challenges, and fear of cancer recurrence. To examine long-term survivorship issues, CanSORT routinely administers follow-up surveys to patients that were enrolled in baseline surveys shortly after diagnosis. Over nearly the past 10 years, CanSORT research in these areas set the framework for the primary focus of the current research program which is on challenges of individualizing surgical and systemic treatments for cancer patients. This area of research has become critically important for breast and prostate cancer in particular as there is growing risk of these diseases being overtreated.
National Institutes of Health: Partner Engagement and Receipt of Surveillance in Colorectal Cancer Survivors (K07 CA196752, P.I. Christine Veenstra, MD, MSHP) The goal of this study is to understand the effect of partner engagement on colorectal cancer survivors’ receipt of surveillance testing. The specific aims are to 1) To identify, through in-depth interviews, factors that influence the receipt of surveillance from the perspective of survivors of colorectal cancer and their partners; 2) To determine, through a survey of colorectal cancer survivors and their partners, the partner-specific factors associated with a high level of partner engagement in the patient’s surveillance care process; and 3) To determine via survey of patients and partners the relationship between level of partner engagement and patients’ receipt of surveillance.